Angiotensin Converting Enzyme Inhibitors Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Angiotensin Converting Enzyme Inhibitors Market was valued at US$ 11,693.6 million in 2017, and is expected to witness a CAGR of 3% during the forecast period 2021 – 2027.

Angiotensin-converting enzyme inhibitors are a group of drugs used to treat heart failure, high blood pressure (high blood pressure), or reduce complications of myocardial infarction (heart attack). These drugs are also useful to slow the progression of kidney disease in people with chronic kidney disease or to slow kidney disease in people with diabetes. The mechanism of action of geotensin converting enzyme inhibitors is to decrease the amount of geotensin II produced. Angiotensin II acts on the body to increase pressure in the kidneys, blood volume and blood pressure.

Market Segments

On the basis of product

● Benazepril (Lotensin)
● Captopril
● Enalapril (Vasotec)
● Fosinopril
● Lisinopril (Prinivil, Zestril)
● Moexipril
● Perindopril
● Quinapril (Accupril)
● Ramipril (Altace)
● Trandolapril

On the basis of the end users/applications

● Coronary Artery Disease
● Heart Failure
● Diabetes
● Chronic Kidney Diseases
● Heart Attacks
● Scleroderma
● Migraines
● Others

Key Players

Key players operating in the angiotensin converting enzymes (ACE) inhibitors market include, Pfizer, Inc., AstraZeneca Pharmaceutical Company, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Merck KGaA, Takeda Pharmaceutical Company, and  Bayer AG.

Scope of the Report

The research study analyzes the global Angiotensin Converting Enzyme Inhibitors industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Angiotensin Converting Enzyme Inhibitors Market Report

1. What was the Angiotensin Converting Enzyme Inhibitors Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Angiotensin Converting Enzyme Inhibitors Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Angiotensin Converting Enzyme Inhibitors Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.